Expressing support for the designation of May 17, 2025, as "DIPG Awareness Day" to raise awareness and encourage research into cures for diffuse intrinsic pontine glioma (DIPG) and pediatric cancers in general. | ChamberLight
Bills · HRES 419
IN COMMITTEE· 119TH CONGRESS
House Res.HRES 419Health
Expressing support for the designation of May 17, 2025, as "DIPG Awareness Day" to raise awareness and encourage research into cures for diffuse intrinsic pontine glioma (DIPG) and pediatric cancers in general.
INTRO MAY 15· LAST ACTION MAY 15
READING
2MIN
COSPONSORS
11
READER REACTIONS0 TOTAL
NO VOTES YET · BE THE FIRST
Non-binding
LEGISLATIVE PROGRESS
STEP 2 / 8
Introduced
In Committee
Reported
Passed House
Passed Senate
Conference
To President
Became Law
WHAT THE BILL DOES
AI-written
This resolution matters because it shines a spotlight on a particularly aggressive and often fatal childhood cancer, DIPG, which currently has very few effective treatments and a dismal survival rate. By formally expressing support for an awareness day and encouraging expanded research, it signals a Congressional interest in addressing this critical public health issue.
If this resolution is passed, it could indirectly influence public and private funding decisions, potentially directing more resources towards research that could lead to new treatments or even cures for DIPG and other pediatric cancers. Without such a resolution, the unique challenges and devastating impact of DIPG might not receive the same level of attention, potentially delaying progress in a field where breakthroughs are desperately needed to save young lives.
KEY PROVISIONS
4AI-extracted
PROVISION 01
Supports the designation of May 17, 2025, as "DIPG Awareness Day."
This formal support aims to elevate public recognition and understanding of this rare and deadly pediatric brain cancer.
PROVISION 02
Encourages all people in the United States to become more informed about DIPG, pediatric brain cancer, and current challenges in research funding.
Increased public awareness can build support for advocacy and funding efforts for pediatric cancer research.
PROVISION 03
Supports expanded research to better understand DIPG, develop effective treatments, and provide comprehensive care for children with DIPG and their families.
This expresses a desire for more scientific and medical efforts to combat this severe disease, potentially leading to breakthroughs.
PROVISION 04
Encourages public and private research funders to consider the mortality rate of a cancer and the 'life-years lost' as significant factors during the grant application process.
This provision aims to prioritize funding for diseases like DIPG that kill young people and result in significant lost years of life, making research more impactful.
IN COMMITTEE· 119TH CONGRESS · ENERGY AND COMMERCE COMMITTEE · INTRODUCED MAY 15, 2025
House Res.HRES 419Health
Expressing support for the designation of May 17, 2025, as "DIPG Awareness Day" to raise awareness and encourage research into cures for diffuse intrinsic pontine glioma (DIPG) and pediatric cancers in general.
This resolution matters because it shines a spotlight on a particularly aggressive and often fatal childhood cancer, DIPG, which currently has very few effective treatments and a dismal survival rate. By formally expressing support for an awareness day and encouraging expanded research, it signals a Congressional interest in addressing this critical public health issue.
If this resolution is passed, it could indirectly influence public and private funding decisions, potentially directing more resources towards research that could lead to new treatments or even cures for DIPG and other pediatric cancers. Without such a resolution, the unique challenges and devastating impact of DIPG might not receive the same level of attention, potentially delaying progress in a field where breakthroughs are desperately needed to save young lives.
KEY PROVISIONS
AI-extracted
med
Supports the designation of May 17, 2025, as "DIPG Awareness Day."
This formal support aims to elevate public recognition and understanding of this rare and deadly pediatric brain cancer.
med
Encourages all people in the United States to become more informed about DIPG, pediatric brain cancer, and current challenges in research funding.
Increased public awareness can build support for advocacy and funding efforts for pediatric cancer research.
high
Supports expanded research to better understand DIPG, develop effective treatments, and provide comprehensive care for children with DIPG and their families.
This expresses a desire for more scientific and medical efforts to combat this severe disease, potentially leading to breakthroughs.
high
Encourages public and private research funders to consider the mortality rate of a cancer and the 'life-years lost' as significant factors during the grant application process.
This provision aims to prioritize funding for diseases like DIPG that kill young people and result in significant lost years of life, making research more impactful.
A rare and very aggressive type of brain tumor that forms in the brainstem, primarily affecting children and having a very poor prognosis.
Pediatric Cancer
Any type of cancer that develops in children, typically from birth through adolescence.
Resolution (Congressional)
A legislative measure that does not become a public law but is used by a legislative body (like the House of Representatives) to express its opinion, support a cause, or address procedural matters.
Life-Years Lost
A public health measure that quantifies the total number of years an individual would have lived if they had not died prematurely due to a specific disease or condition.
Prognosis
The likely course or outcome of a disease or medical condition; the outlook for recovery or survival.
Malignant Brain Tumor
A cancerous growth within the brain that can spread and often has serious health implications.
ACTION TIMELINE
2 EVENTS
MAY 15, 25
Submitted in House
INTROREFERRAL
MAY 15, 25
Referred to the House Committee on Energy and Commerce.